Oppenheimer Cuts enGene (NASDAQ:ENGN) Price Target to $30.00
enGene (NASDAQ:ENGN – Get Free Report) had its price objective lowered by stock analysts at Oppenheimer from $33.00 to $30.00 in a research report issued on Wednesday,Benzinga reports. The firm currently has an “outperform” rating on the stock. Oppenheimer’s price target would indicate a potential upside of 336.68% from the company’s previous close. Other analysts [...]